The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Genital Herpes Research and Development Pipeline Market Research Report 2025
Synopsis
The global Genital Herpes Research and Development Pipeline market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Genital Herpes Research and Development Pipeline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genital Herpes Research and Development Pipeline.
Report Scope
The Genital Herpes Research and Development Pipeline market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genital Herpes Research and Development Pipeline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genital Herpes Research and Development Pipeline companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AiCuris GmbH & Co. KG
AlphaVax, Inc.
Foamix Pharmaceuticals Ltd.
Genocea Biosciences, Inc.
GenVec, Inc.
Immune Design Corp.
Immunovaccine, Inc.
Mymetics Corporation
NanoBio Corporation
NanoViricides, Inc.
PaxVax
Profectus BioSciences, Inc.
Sanofi Pasteur SA
Spider Biotech
Starpharma Holdings Limited
Vaccibody AS
Vaxart, Inc.
Vical Incorporated.
Segment by Type
Acyclovir
Aspidasept
G-103
GEN-003
GV-2207
HerpeCide-I
HSV-529
Pritelivir
SB-105A10
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genital Herpes Research and Development Pipeline companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Genital Herpes Research and Development Pipeline market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Genital Herpes Research and Development Pipeline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genital Herpes Research and Development Pipeline.
Report Scope
The Genital Herpes Research and Development Pipeline market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genital Herpes Research and Development Pipeline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genital Herpes Research and Development Pipeline companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AiCuris GmbH & Co. KG
AlphaVax, Inc.
Foamix Pharmaceuticals Ltd.
Genocea Biosciences, Inc.
GenVec, Inc.
Immune Design Corp.
Immunovaccine, Inc.
Mymetics Corporation
NanoBio Corporation
NanoViricides, Inc.
PaxVax
Profectus BioSciences, Inc.
Sanofi Pasteur SA
Spider Biotech
Starpharma Holdings Limited
Vaccibody AS
Vaxart, Inc.
Vical Incorporated.
Segment by Type
Acyclovir
Aspidasept
G-103
GEN-003
GV-2207
HerpeCide-I
HSV-529
Pritelivir
SB-105A10
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genital Herpes Research and Development Pipeline companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genital Herpes Research and Development Pipeline Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Acyclovir
1.2.3 Aspidasept
1.2.4 G-103
1.2.5 GEN-003
1.2.6 GV-2207
1.2.7 HerpeCide-I
1.2.8 HSV-529
1.2.9 Pritelivir
1.2.10 SB-105A10
1.3 Market by Application
1.3.1 Global Genital Herpes Research and Development Pipeline Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genital Herpes Research and Development Pipeline Market Perspective (2019-2030)
2.2 Genital Herpes Research and Development Pipeline Growth Trends by Region
2.2.1 Global Genital Herpes Research and Development Pipeline Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genital Herpes Research and Development Pipeline Historic Market Size by Region (2019-2024)
2.2.3 Genital Herpes Research and Development Pipeline Forecasted Market Size by Region (2025-2030)
2.3 Genital Herpes Research and Development Pipeline Market Dynamics
2.3.1 Genital Herpes Research and Development Pipeline Industry Trends
2.3.2 Genital Herpes Research and Development Pipeline Market Drivers
2.3.3 Genital Herpes Research and Development Pipeline Market Challenges
2.3.4 Genital Herpes Research and Development Pipeline Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genital Herpes Research and Development Pipeline Players by Revenue
3.1.1 Global Top Genital Herpes Research and Development Pipeline Players by Revenue (2019-2024)
3.1.2 Global Genital Herpes Research and Development Pipeline Revenue Market Share by Players (2019-2024)
3.2 Global Genital Herpes Research and Development Pipeline Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genital Herpes Research and Development Pipeline Revenue
3.4 Global Genital Herpes Research and Development Pipeline Market Concentration Ratio
3.4.1 Global Genital Herpes Research and Development Pipeline Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genital Herpes Research and Development Pipeline Revenue in 2023
3.5 Genital Herpes Research and Development Pipeline Key Players Head office and Area Served
3.6 Key Players Genital Herpes Research and Development Pipeline Product Solution and Service
3.7 Date of Enter into Genital Herpes Research and Development Pipeline Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genital Herpes Research and Development Pipeline Breakdown Data by Type
4.1 Global Genital Herpes Research and Development Pipeline Historic Market Size by Type (2019-2024)
4.2 Global Genital Herpes Research and Development Pipeline Forecasted Market Size by Type (2025-2030)
5 Genital Herpes Research and Development Pipeline Breakdown Data by Application
5.1 Global Genital Herpes Research and Development Pipeline Historic Market Size by Application (2019-2024)
5.2 Global Genital Herpes Research and Development Pipeline Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Genital Herpes Research and Development Pipeline Market Size (2019-2030)
6.2 North America Genital Herpes Research and Development Pipeline Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genital Herpes Research and Development Pipeline Market Size by Country (2019-2024)
6.4 North America Genital Herpes Research and Development Pipeline Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genital Herpes Research and Development Pipeline Market Size (2019-2030)
7.2 Europe Genital Herpes Research and Development Pipeline Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genital Herpes Research and Development Pipeline Market Size by Country (2019-2024)
7.4 Europe Genital Herpes Research and Development Pipeline Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genital Herpes Research and Development Pipeline Market Size (2019-2030)
8.2 Asia-Pacific Genital Herpes Research and Development Pipeline Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genital Herpes Research and Development Pipeline Market Size by Region (2019-2024)
8.4 Asia-Pacific Genital Herpes Research and Development Pipeline Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genital Herpes Research and Development Pipeline Market Size (2019-2030)
9.2 Latin America Genital Herpes Research and Development Pipeline Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genital Herpes Research and Development Pipeline Market Size by Country (2019-2024)
9.4 Latin America Genital Herpes Research and Development Pipeline Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genital Herpes Research and Development Pipeline Market Size (2019-2030)
10.2 Middle East & Africa Genital Herpes Research and Development Pipeline Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genital Herpes Research and Development Pipeline Market Size by Country (2019-2024)
10.4 Middle East & Africa Genital Herpes Research and Development Pipeline Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AiCuris GmbH & Co. KG
11.1.1 AiCuris GmbH & Co. KG Company Detail
11.1.2 AiCuris GmbH & Co. KG Business Overview
11.1.3 AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Introduction
11.1.4 AiCuris GmbH & Co. KG Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.1.5 AiCuris GmbH & Co. KG Recent Development
11.2 AlphaVax, Inc.
11.2.1 AlphaVax, Inc. Company Detail
11.2.2 AlphaVax, Inc. Business Overview
11.2.3 AlphaVax, Inc. Genital Herpes Research and Development Pipeline Introduction
11.2.4 AlphaVax, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.2.5 AlphaVax, Inc. Recent Development
11.3 Foamix Pharmaceuticals Ltd.
11.3.1 Foamix Pharmaceuticals Ltd. Company Detail
11.3.2 Foamix Pharmaceuticals Ltd. Business Overview
11.3.3 Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Introduction
11.3.4 Foamix Pharmaceuticals Ltd. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.3.5 Foamix Pharmaceuticals Ltd. Recent Development
11.4 Genocea Biosciences, Inc.
11.4.1 Genocea Biosciences, Inc. Company Detail
11.4.2 Genocea Biosciences, Inc. Business Overview
11.4.3 Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Introduction
11.4.4 Genocea Biosciences, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.4.5 Genocea Biosciences, Inc. Recent Development
11.5 GenVec, Inc.
11.5.1 GenVec, Inc. Company Detail
11.5.2 GenVec, Inc. Business Overview
11.5.3 GenVec, Inc. Genital Herpes Research and Development Pipeline Introduction
11.5.4 GenVec, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.5.5 GenVec, Inc. Recent Development
11.6 Immune Design Corp.
11.6.1 Immune Design Corp. Company Detail
11.6.2 Immune Design Corp. Business Overview
11.6.3 Immune Design Corp. Genital Herpes Research and Development Pipeline Introduction
11.6.4 Immune Design Corp. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.6.5 Immune Design Corp. Recent Development
11.7 Immunovaccine, Inc.
11.7.1 Immunovaccine, Inc. Company Detail
11.7.2 Immunovaccine, Inc. Business Overview
11.7.3 Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Introduction
11.7.4 Immunovaccine, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.7.5 Immunovaccine, Inc. Recent Development
11.8 Mymetics Corporation
11.8.1 Mymetics Corporation Company Detail
11.8.2 Mymetics Corporation Business Overview
11.8.3 Mymetics Corporation Genital Herpes Research and Development Pipeline Introduction
11.8.4 Mymetics Corporation Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.8.5 Mymetics Corporation Recent Development
11.9 NanoBio Corporation
11.9.1 NanoBio Corporation Company Detail
11.9.2 NanoBio Corporation Business Overview
11.9.3 NanoBio Corporation Genital Herpes Research and Development Pipeline Introduction
11.9.4 NanoBio Corporation Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.9.5 NanoBio Corporation Recent Development
11.10 NanoViricides, Inc.
11.10.1 NanoViricides, Inc. Company Detail
11.10.2 NanoViricides, Inc. Business Overview
11.10.3 NanoViricides, Inc. Genital Herpes Research and Development Pipeline Introduction
11.10.4 NanoViricides, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.10.5 NanoViricides, Inc. Recent Development
11.11 PaxVax
11.11.1 PaxVax Company Detail
11.11.2 PaxVax Business Overview
11.11.3 PaxVax Genital Herpes Research and Development Pipeline Introduction
11.11.4 PaxVax Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.11.5 PaxVax Recent Development
11.12 Profectus BioSciences, Inc.
11.12.1 Profectus BioSciences, Inc. Company Detail
11.12.2 Profectus BioSciences, Inc. Business Overview
11.12.3 Profectus BioSciences, Inc. Genital Herpes Research and Development Pipeline Introduction
11.12.4 Profectus BioSciences, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.12.5 Profectus BioSciences, Inc. Recent Development
11.13 Sanofi Pasteur SA
11.13.1 Sanofi Pasteur SA Company Detail
11.13.2 Sanofi Pasteur SA Business Overview
11.13.3 Sanofi Pasteur SA Genital Herpes Research and Development Pipeline Introduction
11.13.4 Sanofi Pasteur SA Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.13.5 Sanofi Pasteur SA Recent Development
11.14 Spider Biotech
11.14.1 Spider Biotech Company Detail
11.14.2 Spider Biotech Business Overview
11.14.3 Spider Biotech Genital Herpes Research and Development Pipeline Introduction
11.14.4 Spider Biotech Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.14.5 Spider Biotech Recent Development
11.15 Starpharma Holdings Limited
11.15.1 Starpharma Holdings Limited Company Detail
11.15.2 Starpharma Holdings Limited Business Overview
11.15.3 Starpharma Holdings Limited Genital Herpes Research and Development Pipeline Introduction
11.15.4 Starpharma Holdings Limited Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.15.5 Starpharma Holdings Limited Recent Development
11.16 Vaccibody AS
11.16.1 Vaccibody AS Company Detail
11.16.2 Vaccibody AS Business Overview
11.16.3 Vaccibody AS Genital Herpes Research and Development Pipeline Introduction
11.16.4 Vaccibody AS Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.16.5 Vaccibody AS Recent Development
11.17 Vaxart, Inc.
11.17.1 Vaxart, Inc. Company Detail
11.17.2 Vaxart, Inc. Business Overview
11.17.3 Vaxart, Inc. Genital Herpes Research and Development Pipeline Introduction
11.17.4 Vaxart, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.17.5 Vaxart, Inc. Recent Development
11.18 Vical Incorporated.
11.18.1 Vical Incorporated. Company Detail
11.18.2 Vical Incorporated. Business Overview
11.18.3 Vical Incorporated. Genital Herpes Research and Development Pipeline Introduction
11.18.4 Vical Incorporated. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024)
11.18.5 Vical Incorporated. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Genital Herpes Research and Development Pipeline Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Acyclovir
Table 3. Key Players of Aspidasept
Table 4. Key Players of G-103
Table 5. Key Players of GEN-003
Table 6. Key Players of GV-2207
Table 7. Key Players of HerpeCide-I
Table 8. Key Players of HSV-529
Table 9. Key Players of Pritelivir
Table 10. Key Players of SB-105A10
Table 11. Global Genital Herpes Research and Development Pipeline Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Genital Herpes Research and Development Pipeline Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 13. Global Genital Herpes Research and Development Pipeline Market Size by Region (2019-2024) & (US$ Million)
Table 14. Global Genital Herpes Research and Development Pipeline Market Share by Region (2019-2024)
Table 15. Global Genital Herpes Research and Development Pipeline Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 16. Global Genital Herpes Research and Development Pipeline Market Share by Region (2025-2030)
Table 17. Genital Herpes Research and Development Pipeline Market Trends
Table 18. Genital Herpes Research and Development Pipeline Market Drivers
Table 19. Genital Herpes Research and Development Pipeline Market Challenges
Table 20. Genital Herpes Research and Development Pipeline Market Restraints
Table 21. Global Genital Herpes Research and Development Pipeline Revenue by Players (2019-2024) & (US$ Million)
Table 22. Global Genital Herpes Research and Development Pipeline Market Share by Players (2019-2024)
Table 23. Global Top Genital Herpes Research and Development Pipeline Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Research and Development Pipeline as of 2023)
Table 24. Ranking of Global Top Genital Herpes Research and Development Pipeline Companies by Revenue (US$ Million) in 2023
Table 25. Global 5 Largest Players Market Share by Genital Herpes Research and Development Pipeline Revenue (CR5 and HHI) & (2019-2024)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Genital Herpes Research and Development Pipeline Product Solution and Service
Table 28. Date of Enter into Genital Herpes Research and Development Pipeline Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Genital Herpes Research and Development Pipeline Market Size by Type (2019-2024) & (US$ Million)
Table 31. Global Genital Herpes Research and Development Pipeline Revenue Market Share by Type (2019-2024)
Table 32. Global Genital Herpes Research and Development Pipeline Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 33. Global Genital Herpes Research and Development Pipeline Revenue Market Share by Type (2025-2030)
Table 34. Global Genital Herpes Research and Development Pipeline Market Size by Application (2019-2024) & (US$ Million)
Table 35. Global Genital Herpes Research and Development Pipeline Revenue Market Share by Application (2019-2024)
Table 36. Global Genital Herpes Research and Development Pipeline Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 37. Global Genital Herpes Research and Development Pipeline Revenue Market Share by Application (2025-2030)
Table 38. North America Genital Herpes Research and Development Pipeline Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. North America Genital Herpes Research and Development Pipeline Market Size by Country (2019-2024) & (US$ Million)
Table 40. North America Genital Herpes Research and Development Pipeline Market Size by Country (2025-2030) & (US$ Million)
Table 41. Europe Genital Herpes Research and Development Pipeline Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Europe Genital Herpes Research and Development Pipeline Market Size by Country (2019-2024) & (US$ Million)
Table 43. Europe Genital Herpes Research and Development Pipeline Market Size by Country (2025-2030) & (US$ Million)
Table 44. Asia-Pacific Genital Herpes Research and Development Pipeline Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 45. Asia-Pacific Genital Herpes Research and Development Pipeline Market Size by Region (2019-2024) & (US$ Million)
Table 46. Asia-Pacific Genital Herpes Research and Development Pipeline Market Size by Region (2025-2030) & (US$ Million)
Table 47. Latin America Genital Herpes Research and Development Pipeline Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Latin America Genital Herpes Research and Development Pipeline Market Size by Country (2019-2024) & (US$ Million)
Table 49. Latin America Genital Herpes Research and Development Pipeline Market Size by Country (2025-2030) & (US$ Million)
Table 50. Middle East & Africa Genital Herpes Research and Development Pipeline Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 51. Middle East & Africa Genital Herpes Research and Development Pipeline Market Size by Country (2019-2024) & (US$ Million)
Table 52. Middle East & Africa Genital Herpes Research and Development Pipeline Market Size by Country (2025-2030) & (US$ Million)
Table 53. AiCuris GmbH & Co. KG Company Detail
Table 54. AiCuris GmbH & Co. KG Business Overview
Table 55. AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Product
Table 56. AiCuris GmbH & Co. KG Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 57. AiCuris GmbH & Co. KG Recent Development
Table 58. AlphaVax, Inc. Company Detail
Table 59. AlphaVax, Inc. Business Overview
Table 60. AlphaVax, Inc. Genital Herpes Research and Development Pipeline Product
Table 61. AlphaVax, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 62. AlphaVax, Inc. Recent Development
Table 63. Foamix Pharmaceuticals Ltd. Company Detail
Table 64. Foamix Pharmaceuticals Ltd. Business Overview
Table 65. Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Product
Table 66. Foamix Pharmaceuticals Ltd. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 67. Foamix Pharmaceuticals Ltd. Recent Development
Table 68. Genocea Biosciences, Inc. Company Detail
Table 69. Genocea Biosciences, Inc. Business Overview
Table 70. Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Product
Table 71. Genocea Biosciences, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 72. Genocea Biosciences, Inc. Recent Development
Table 73. GenVec, Inc. Company Detail
Table 74. GenVec, Inc. Business Overview
Table 75. GenVec, Inc. Genital Herpes Research and Development Pipeline Product
Table 76. GenVec, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 77. GenVec, Inc. Recent Development
Table 78. Immune Design Corp. Company Detail
Table 79. Immune Design Corp. Business Overview
Table 80. Immune Design Corp. Genital Herpes Research and Development Pipeline Product
Table 81. Immune Design Corp. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 82. Immune Design Corp. Recent Development
Table 83. Immunovaccine, Inc. Company Detail
Table 84. Immunovaccine, Inc. Business Overview
Table 85. Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Product
Table 86. Immunovaccine, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 87. Immunovaccine, Inc. Recent Development
Table 88. Mymetics Corporation Company Detail
Table 89. Mymetics Corporation Business Overview
Table 90. Mymetics Corporation Genital Herpes Research and Development Pipeline Product
Table 91. Mymetics Corporation Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 92. Mymetics Corporation Recent Development
Table 93. NanoBio Corporation Company Detail
Table 94. NanoBio Corporation Business Overview
Table 95. NanoBio Corporation Genital Herpes Research and Development Pipeline Product
Table 96. NanoBio Corporation Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 97. NanoBio Corporation Recent Development
Table 98. NanoViricides, Inc. Company Detail
Table 99. NanoViricides, Inc. Business Overview
Table 100. NanoViricides, Inc. Genital Herpes Research and Development Pipeline Product
Table 101. NanoViricides, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 102. NanoViricides, Inc. Recent Development
Table 103. PaxVax Company Detail
Table 104. PaxVax Business Overview
Table 105. PaxVax Genital Herpes Research and Development Pipeline Product
Table 106. PaxVax Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 107. PaxVax Recent Development
Table 108. Profectus BioSciences, Inc. Company Detail
Table 109. Profectus BioSciences, Inc. Business Overview
Table 110. Profectus BioSciences, Inc. Genital Herpes Research and Development Pipeline Product
Table 111. Profectus BioSciences, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 112. Profectus BioSciences, Inc. Recent Development
Table 113. Sanofi Pasteur SA Company Detail
Table 114. Sanofi Pasteur SA Business Overview
Table 115. Sanofi Pasteur SA Genital Herpes Research and Development Pipeline Product
Table 116. Sanofi Pasteur SA Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 117. Sanofi Pasteur SA Recent Development
Table 118. Spider Biotech Company Detail
Table 119. Spider Biotech Business Overview
Table 120. Spider Biotech Genital Herpes Research and Development Pipeline Product
Table 121. Spider Biotech Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 122. Spider Biotech Recent Development
Table 123. Starpharma Holdings Limited Company Detail
Table 124. Starpharma Holdings Limited Business Overview
Table 125. Starpharma Holdings Limited Genital Herpes Research and Development Pipeline Product
Table 126. Starpharma Holdings Limited Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 127. Starpharma Holdings Limited Recent Development
Table 128. Vaccibody AS Company Detail
Table 129. Vaccibody AS Business Overview
Table 130. Vaccibody AS Genital Herpes Research and Development Pipeline Product
Table 131. Vaccibody AS Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 132. Vaccibody AS Recent Development
Table 133. Vaxart, Inc. Company Detail
Table 134. Vaxart, Inc. Business Overview
Table 135. Vaxart, Inc. Genital Herpes Research and Development Pipeline Product
Table 136. Vaxart, Inc. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 137. Vaxart, Inc. Recent Development
Table 138. Vical Incorporated. Company Detail
Table 139. Vical Incorporated. Business Overview
Table 140. Vical Incorporated. Genital Herpes Research and Development Pipeline Product
Table 141. Vical Incorporated. Revenue in Genital Herpes Research and Development Pipeline Business (2019-2024) & (US$ Million)
Table 142. Vical Incorporated. Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genital Herpes Research and Development Pipeline Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Genital Herpes Research and Development Pipeline Market Share by Type: 2023 VS 2030
Figure 3. Acyclovir Features
Figure 4. Aspidasept Features
Figure 5. G-103 Features
Figure 6. GEN-003 Features
Figure 7. GV-2207 Features
Figure 8. HerpeCide-I Features
Figure 9. HSV-529 Features
Figure 10. Pritelivir Features
Figure 11. SB-105A10 Features
Figure 12. Global Genital Herpes Research and Development Pipeline Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 13. Global Genital Herpes Research and Development Pipeline Market Share by Application: 2023 VS 2030
Figure 14. Hospital Case Studies
Figure 15. Clinic Case Studies
Figure 16. Genital Herpes Research and Development Pipeline Report Years Considered
Figure 17. Global Genital Herpes Research and Development Pipeline Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Genital Herpes Research and Development Pipeline Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Genital Herpes Research and Development Pipeline Market Share by Region: 2023 VS 2030
Figure 20. Global Genital Herpes Research and Development Pipeline Market Share by Players in 2023
Figure 21. Global Top Genital Herpes Research and Development Pipeline Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genital Herpes Research and Development Pipeline as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Genital Herpes Research and Development Pipeline Revenue in 2023
Figure 23. North America Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Genital Herpes Research and Development Pipeline Market Share by Country (2019-2030)
Figure 25. United States Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Genital Herpes Research and Development Pipeline Market Share by Country (2019-2030)
Figure 29. Germany Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Genital Herpes Research and Development Pipeline Market Share by Region (2019-2030)
Figure 37. China Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Genital Herpes Research and Development Pipeline Market Share by Country (2019-2030)
Figure 45. Mexico Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Genital Herpes Research and Development Pipeline Market Share by Country (2019-2030)
Figure 49. Turkey Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Genital Herpes Research and Development Pipeline Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. AiCuris GmbH & Co. KG Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 52. AlphaVax, Inc. Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 53. Foamix Pharmaceuticals Ltd. Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 54. Genocea Biosciences, Inc. Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 55. GenVec, Inc. Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 56. Immune Design Corp. Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 57. Immunovaccine, Inc. Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 58. Mymetics Corporation Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 59. NanoBio Corporation Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 60. NanoViricides, Inc. Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 61. PaxVax Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 62. Profectus BioSciences, Inc. Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 63. Sanofi Pasteur SA Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 64. Spider Biotech Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 65. Starpharma Holdings Limited Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 66. Vaccibody AS Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 67. Vaxart, Inc. Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 68. Vical Incorporated. Revenue Growth Rate in Genital Herpes Research and Development Pipeline Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
